(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Designates February 25, 2005, as National MPS Awareness Day (mucopolysaccharidosis and mucolipidosis disorders are genetically determined lysosomal storage disorders that result in the inability of the body to produce certain enzymes needed to break down complex carbohydrates).
[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 57 Agreed to Senate (ATS)]
109th CONGRESS
1st Session
S. RES. 57
Designating February 25, 2005, as ``National MPS Awareness Day''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
February 16, 2005
Mr. Graham (for himself, Mr. Specter, Mr. Brownback, Mr. Kohl, Mr.
Hatch, Mr. Feingold, Ms. Cantwell, Mr. Chambliss, Mrs. Murray, Mrs.
Dole, Mr. Santorum, and Mr. Jeffords) submitted the following
resolution; which was considered and agreed to
_______________________________________________________________________
RESOLUTION
Designating February 25, 2005, as ``National MPS Awareness Day''.
Whereas Mucopolysaccharidosis (``MPS'') and Mucolipidosis (``ML'') disorders are
genetically determined lysosomal storage disorders that result in the
body's inability to produce certain enzymes needed to breakdown complex
carbohydrates;
Whereas these complex carbohydrates are then stored in virtually every cell in
the body and progressively cause damage to these cells, adversely
affecting an individual's body, including an individual's heart,
respiratory system, bones, internal organs, and central nervous system;
Whereas the cellular damage caused by MPS often results in mental retardation,
short stature, corneal damage, joint stiffness, loss of mobility, speech
and hearing impairment, heart disease, hyperactivity, chronic
respiratory problems, and most importantly, a drastically shortened life
span;
Whereas the nature of the disorder is usually not apparent at birth;
Whereas without treatment, life expectancy of an individual afflicted with MPS
is usually very early in life;
Whereas recent research developments have resulted in limited treatments for
some MPS disorders;
Whereas promising advancements are underway in pursuit of treatments for
additional MPS disorders;
Whereas despite newly developed remedies, the blood brain barrier continues to
be a significant impediment to effectively treating the brain, thereby
preventing the treatment of many of the symptoms of MPS;
Whereas treatments for MPS will be greatly enhanced with continued public
funding;
Whereas the quality of life for individuals afflicted with MPS and the
treatments available to them will be enhanced through the development of
early detection techniques and early intervention;
Whereas treatments and research advancements for MPS are limited by a lack of
awareness about MPS disorders;
Whereas the lack of awareness about MPS disorders extends to those within the
medical community;
Whereas the damage that is caused by MPS makes it a model for many other
degenerative genetic disorders;
Whereas the development of effective therapies and a potential cure for MPS
disorders can be accomplished by increased awareness, research, data
collection, and information distribution;
Whereas the Senate is an institution than can raise public awareness about MPS;
and
Whereas the Senate is also an institution that can assist in encouraging and
facilitating increased public and private sector research for early
diagnosis and treatments of MPS disorders: Now, therefore, be it
Resolved, That the Senate--
(1) designates February 25, 2005, as ``National MPS
Awareness Day''; and
(2) supports the goals and ideals of ``National MPS
Awareness Day''.
<all>
Introduced in Senate
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.(consideration: CR S1577-1578; text as passed Senate: CR S1578; text of measure as introduced: CR S1560)
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1577-1578; text as passed Senate: CR S1578; text of measure as introduced: CR S1560)
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line